TeraRecon provides advanced visualization and artificial intelligence solutions for medical imaging.

TeraRecon

TeraRecon, Inc. | 10,627 followers on LinkedIn. A ConcertAI company that is a solution provider for AI-empowered radiology, oncology, cardiology, neurology, and more. | Serving ~1,900 clinical sites globally, TeraRecon, a ConcertAI company, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer&#39;s imaging equipment or PACS system, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights.

Jan Hardenbergh

Kevin Sean Lev

Director, Solution Support at TeraRecon, Inc.

Srinivasan Sukumar

Chikako Goodman

TeraRecon, Inc.

Detecting and proactively addressing heart-related conditions involving the mitral valve and left atrial appendage can be challenging, particularly when it comes to reducing stroke risks in atrial fibrillation patients or treating diseases in the early stages. Read our white paper to dig deeper into some of the challenges faced in the diagnosis and treatment of structural heart diseases, including the repair and replacement of damaged heart valves or/and reducing the risk of thrombus formation in the heart. Download the white paper now: https://hubs.ly/Q02qZnTp0 #structuralheart #whitepaper #medicalimaging

Intuition 4.10, TeraRecon's latest advanced visualization software, is our most significant update in years. With AI productivity, novel cardiac MR medical imaging workflows, and over 200 other enhancements, Intuition 4.10 delivers even greater precision for cardiac CT and MR. Plus, it's now available on a robust, cloud-based SaaS platform – part of our entire portfolio of cloud-enabled solutions. We can't wait to show you all that 4.10 has to offer! If you're planning to be at RSNA Annual Meeting in Chicago (Dec. 1-5), we'd love to give you a tour and demonstrate the breadth and depth of our end-to-end, AI-enabled advanced visualization clinical workflows. Schedule a meeting with TeraRecon at RSNA 2024: https://hubs.ly/Q02Xc-PJ0 #AdvancedVisualization #TeraRecon #CardiacMR #CardiacCT #RSNA

When undertreatment can lead to disease recurrence and overtreatment to unnecessary complications in liver or kidney ablation therapy, you need a careful planning tool. Did you know that TeraRecon's segmentation workflows can guide ablation therapy and help you carefully plan your procedures to maximize treatment success? If you're planning to be at RSNA Annual Meeting in Chicago (Dec. 1-5), let us show you the breadth and depth of our end-to-end advanced imaging workflows. Schedule a meeting with TeraRecon at RSNA 2024: https://hubs.ly/Q02WD1Wg0 #AdvancedVisualization #TeraRecon #TreatmentPlanning #RSNA

TeraRecon is excited to announce the release of Intuition 4.10, our latest version of the best-in-class advanced visualization software packed with AI productivity and novel cardiac MR medical imaging workflows. With over 200 enhancements, the new Intuition 4.10 delivers unmatched precision for cardiac CT and MR, and is now available on a robust, cloud-based SaaS platform. "This release allows me to start standardizing my post-processing cardiac workflows onto a single, broad tool for imaging workflows," says Dr. Christopher Maroules MD, COO of Innovation Health Services. "The versatility of the dedicated cardiac MR viewer and various cardiac MR workflows enable me to conduct my day-to-day cardiac MR analysis in a streamlined and consistent manner." Find out more: https://hubs.ly/Q02Vx_f20 #Intuition #AdvancedVisualization #CardiacMR #medicalimaging #AI #SaaS

🎗️ October is Breast Cancer Awareness Month! Let's come together this month to raise awareness, support those affected, and celebrate the incredible progress in breast cancer detection and treatment. We are proud to join forces with ClariPi Inc. by integrating their innovative solution, ClariSIGMAM, into the Eureka Clinical AI platform. ClariSIGMAM aims to dramatically improve the identification of breast tissue abnormalities. Schedule a meeting to learn more about ClariPi’s solutions available on the Eureka Clinical AI platform: https://hubs.ly/Q02TXrl70 #pinktober #BreastCancerAwarenessMonth #breastdensity #ClariPi #TeraRecon

RSNA 2024 will be here before you know it -- will we see you there? Come explore our latest updates and find out why TeraRecon is an award-winning solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Let us show you how Intuition and Eureka can deliver clinical decision support across your enterprise. Schedule a meeting in advance: https://hubs.ly/Q02PTr8W0 #RSNA24 #healthcareinnovation #AI #EurekaClinicalAI #Intuition #TeraRecon

September is World Alzheimer's Month, an international campaign to raise awareness and to challenge the stigma that persists around Alzheimer’s disease and all types of dementia. With that in mind, we’re spotlighting Combinostics' cMRI solution which is available via TeraRecon’s Eureka Clinical AI platform. Combinostics’ cMRI software is CE-marked and FDA-approved. It provides fully automated brain MRI quantification with focus on dementia. The software assists with objective detection and differentiation of Alzheimer’s disease from other dementia forms. Using T1 and FLAIR sequences, a patient’s individual brain morphometry pattern, white matter hyperintensities, and disease-specific imaging biomarkers are quantified and compared to a large reference database of healthy controls. Learn more about Combinostics' cMRI solution: https://hubs.ly/Q02Qxfvh0 Learn more about the AI solutions available on Eureka Clinical AI: https://hubs.ly/Q02QxwXF0 #WorldAlzheimersMonth #TeraRecon #Eureka #Alzheimers #Combinostics #MRI #MRIquantification

Day one of #BSCI2024 has been a blast! We're very excited to be here and can't wait to keep the conversations going tomorrow. Come by our booth to see our latest #cardiology solutions in action. #BSCCT2024 #radiology #medicalimagining #healthcareinnovation #TeraRecon #ConcertAI https://hubs.ly/Q02QtKHP0

We are excited to be exhibiting at BSCI 2024 in Sheffield, UK this week! Visit us to see our gold-standard Intuition cardiac solutions in action and explore AI cardiac capabilities available on the Eureka Clinical AI platform. #BSCI2024 #BSCCT2024 #cardiology #radiology #TeraRecon #ConcertAI https://hubs.ly/Q02PZqts0

Metric
Company Name	TeraRecon
Symbol
MSH ID	COM:TERARECON
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare Technology
Country	US
Stage
Employee Count
Website	terarecon.com
LinkedIn	terarecon-inc-
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.09M
Web Traffic Growth	-0.24
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

TERA

COM:TERARECON

TeraRecon

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue